Brenner Erin K. 4
4 · Pear Therapeutics, Inc. · Filed Feb 18, 2022
Insider Transaction Report
Form 4
Brenner Erin K.
Chief Product Dev. Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-16+52,520→ 52,520 totalExercise: $4.06Exp: 2032-02-16→ Common Stock (52,520 underlying) - Award
Restricted Stock Units
2022-02-16+66,667→ 66,667 total→ Common Stock (66,667 underlying)
Footnotes (3)
- [F1]25% of the shares underlying the option shall vest on January 14, 2023 and an additional 2.0833 and 1/3% of the shares shall vest on the last day of each calendar month thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F3]The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025.